Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Name | miRBASE accession |
---|---|
hsa-let-7a-5p
|
MIMAT0000062 |
hsa-let-7b-5p
|
MIMAT0000063 |
hsa-let-7c-5p
|
MIMAT0000064 |
hsa-let-7d-5p
|
MIMAT0000065 |
hsa-let-7e-5p
|
MIMAT0000066 |
hsa-let-7f-5p
|
MIMAT0000067 |
hsa-let-7g-5p
|
MIMAT0000414 |
hsa-let-7i-5p
|
MIMAT0000415 |
hsa-miR-4458
|
MIMAT0018980 |
hsa-miR-4500
|
MIMAT0019036 |
hsa-miR-98-5p
|
MIMAT0000096 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_24949026 | 5.21 |
ENST00000539780.5
ENST00000546285.1 ENST00000342945.9 ENST00000261192.12 |
BCAT1
|
branched chain amino acid transaminase 1 |
chr1_+_152514474 | 4.64 |
ENST00000368790.4
|
CRCT1
|
cysteine rich C-terminal 1 |
chr2_-_1744442 | 4.35 |
ENST00000433670.5
ENST00000425171.1 ENST00000252804.9 |
PXDN
|
peroxidasin |
chr19_+_6531018 | 3.57 |
ENST00000245817.5
|
TNFSF9
|
TNF superfamily member 9 |
chrX_-_108438407 | 3.51 |
ENST00000334504.12
ENST00000621266.4 ENST00000538570.5 ENST00000394872.6 ENST00000545689.2 |
COL4A6
|
collagen type IV alpha 6 chain |
chr12_+_4273751 | 3.51 |
ENST00000675880.1
ENST00000261254.8 |
CCND2
|
cyclin D2 |
chr9_+_128411715 | 3.48 |
ENST00000420034.5
ENST00000372842.5 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr1_-_9129085 | 3.40 |
ENST00000377411.5
|
GPR157
|
G protein-coupled receptor 157 |
chr7_-_23470469 | 3.30 |
ENST00000258729.8
|
IGF2BP3
|
insulin like growth factor 2 mRNA binding protein 3 |
chr21_-_26845402 | 3.24 |
ENST00000284984.8
ENST00000676955.1 |
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
chr12_+_65824475 | 3.21 |
ENST00000403681.7
|
HMGA2
|
high mobility group AT-hook 2 |
chr5_-_140346596 | 2.96 |
ENST00000230990.7
|
HBEGF
|
heparin binding EGF like growth factor |
chr5_+_157460173 | 2.90 |
ENST00000435489.7
ENST00000311946.8 |
NIPAL4
|
NIPA like domain containing 4 |
chr13_+_110307276 | 2.88 |
ENST00000360467.7
ENST00000650540.1 |
COL4A2
|
collagen type IV alpha 2 chain |
chr10_+_100347225 | 2.80 |
ENST00000370355.3
|
SCD
|
stearoyl-CoA desaturase |
chr1_-_28176665 | 2.74 |
ENST00000373857.8
|
PTAFR
|
platelet activating factor receptor |
chr15_+_39581068 | 2.71 |
ENST00000397591.2
ENST00000260356.6 |
THBS1
|
thrombospondin 1 |
chr1_+_15409858 | 2.69 |
ENST00000375980.9
|
EFHD2
|
EF-hand domain family member D2 |
chr12_-_68933161 | 2.66 |
ENST00000549781.1
ENST00000551568.6 ENST00000548262.5 |
CPM
|
carboxypeptidase M |
chr17_+_43398984 | 2.56 |
ENST00000320033.5
|
ARL4D
|
ADP ribosylation factor like GTPase 4D |
chr5_+_38846002 | 2.42 |
ENST00000274276.8
|
OSMR
|
oncostatin M receptor |
chr1_-_204151884 | 2.38 |
ENST00000367201.7
|
ETNK2
|
ethanolamine kinase 2 |
chr20_-_5610980 | 2.37 |
ENST00000379019.7
|
GPCPD1
|
glycerophosphocholine phosphodiesterase 1 |
chr6_+_34236865 | 2.34 |
ENST00000674029.1
ENST00000447654.5 ENST00000347617.10 ENST00000401473.7 ENST00000311487.9 |
HMGA1
|
high mobility group AT-hook 1 |
chr2_-_189179754 | 2.30 |
ENST00000374866.9
ENST00000618828.1 |
COL5A2
|
collagen type V alpha 2 chain |
chr7_+_101154445 | 2.21 |
ENST00000337619.11
ENST00000429457.1 |
AP1S1
|
adaptor related protein complex 1 subunit sigma 1 |
chr12_+_1691011 | 2.14 |
ENST00000357103.5
|
ADIPOR2
|
adiponectin receptor 2 |
chr11_+_130448633 | 2.09 |
ENST00000299164.4
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif 15 |
chr2_+_200811882 | 2.04 |
ENST00000409600.6
|
BZW1
|
basic leucine zipper and W2 domains 1 |
chr8_-_143541425 | 2.03 |
ENST00000262577.6
|
ZC3H3
|
zinc finger CCCH-type containing 3 |
chr3_-_86991135 | 1.98 |
ENST00000398399.7
|
VGLL3
|
vestigial like family member 3 |
chr9_-_69672341 | 1.90 |
ENST00000265381.7
|
APBA1
|
amyloid beta precursor protein binding family A member 1 |
chr6_+_36678699 | 1.89 |
ENST00000405375.5
ENST00000244741.10 ENST00000373711.3 |
CDKN1A
|
cyclin dependent kinase inhibitor 1A |
chr8_-_29350666 | 1.88 |
ENST00000240100.7
|
DUSP4
|
dual specificity phosphatase 4 |
chr2_+_74834113 | 1.83 |
ENST00000290573.7
|
HK2
|
hexokinase 2 |
chr6_+_106098933 | 1.82 |
ENST00000369089.3
|
PRDM1
|
PR/SET domain 1 |
chr16_+_2429427 | 1.81 |
ENST00000397066.9
|
CCNF
|
cyclin F |
chr20_+_6767678 | 1.81 |
ENST00000378827.5
|
BMP2
|
bone morphogenetic protein 2 |
chr1_+_37692506 | 1.76 |
ENST00000373055.6
|
CDCA8
|
cell division cycle associated 8 |
chr20_-_47786553 | 1.73 |
ENST00000467815.5
ENST00000359930.8 ENST00000484875.5 |
SULF2
|
sulfatase 2 |
chr22_+_37051731 | 1.71 |
ENST00000610767.4
ENST00000402077.7 ENST00000403888.7 |
KCTD17
|
potassium channel tetramerization domain containing 17 |
chr3_-_52056552 | 1.64 |
ENST00000495880.2
|
DUSP7
|
dual specificity phosphatase 7 |
chr19_+_926001 | 1.64 |
ENST00000263620.8
|
ARID3A
|
AT-rich interaction domain 3A |
chr1_-_153390976 | 1.62 |
ENST00000368732.5
ENST00000368733.4 |
S100A8
|
S100 calcium binding protein A8 |
chr13_-_30307539 | 1.62 |
ENST00000380615.8
|
KATNAL1
|
katanin catalytic subunit A1 like 1 |
chr2_+_10122315 | 1.59 |
ENST00000360566.6
|
RRM2
|
ribonucleotide reductase regulatory subunit M2 |
chr14_-_52695543 | 1.59 |
ENST00000395686.8
|
ERO1A
|
endoplasmic reticulum oxidoreductase 1 alpha |
chr3_+_49171590 | 1.58 |
ENST00000332780.4
|
KLHDC8B
|
kelch domain containing 8B |
chr6_+_12290353 | 1.58 |
ENST00000379375.6
|
EDN1
|
endothelin 1 |
chr12_+_56521798 | 1.56 |
ENST00000262031.10
|
RBMS2
|
RNA binding motif single stranded interacting protein 2 |
chr1_+_203626775 | 1.52 |
ENST00000367218.7
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
chr18_-_12658052 | 1.49 |
ENST00000409402.8
|
SPIRE1
|
spire type actin nucleation factor 1 |
chrX_+_65667645 | 1.49 |
ENST00000360270.7
|
MSN
|
moesin |
chr14_+_75002903 | 1.48 |
ENST00000266126.10
|
EIF2B2
|
eukaryotic translation initiation factor 2B subunit beta |
chr17_-_50201618 | 1.45 |
ENST00000225964.10
|
COL1A1
|
collagen type I alpha 1 chain |
chr1_+_230067198 | 1.45 |
ENST00000366672.5
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2 |
chr19_+_531750 | 1.43 |
ENST00000215574.9
|
CDC34
|
cell division cycle 34, ubiqiutin conjugating enzyme |
chr7_-_24980148 | 1.40 |
ENST00000313367.7
|
OSBPL3
|
oxysterol binding protein like 3 |
chr2_+_69915100 | 1.40 |
ENST00000264444.7
|
MXD1
|
MAX dimerization protein 1 |
chr15_-_45522747 | 1.39 |
ENST00000261867.5
|
SLC30A4
|
solute carrier family 30 member 4 |
chr5_-_132227808 | 1.36 |
ENST00000401867.5
ENST00000379086.5 ENST00000379100.7 ENST00000418055.5 ENST00000453286.5 ENST00000360568.8 ENST00000379104.7 ENST00000166534.8 |
P4HA2
|
prolyl 4-hydroxylase subunit alpha 2 |
chr12_-_109477293 | 1.35 |
ENST00000228495.11
ENST00000542858.1 ENST00000542262.5 |
KCTD10
|
potassium channel tetramerization domain containing 10 |
chr3_-_185498964 | 1.35 |
ENST00000296254.3
|
TMEM41A
|
transmembrane protein 41A |
chr6_+_41638438 | 1.35 |
ENST00000441667.5
ENST00000230321.11 ENST00000373050.8 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr6_-_32190170 | 1.33 |
ENST00000375050.6
|
PBX2
|
PBX homeobox 2 |
chr21_-_41508146 | 1.29 |
ENST00000679054.1
ENST00000678348.1 ENST00000332149.10 ENST00000679016.1 ENST00000678743.1 ENST00000678171.1 ENST00000458356.6 |
TMPRSS2
|
transmembrane serine protease 2 |
chr9_-_35115839 | 1.28 |
ENST00000378566.5
ENST00000322813.10 |
FAM214B
|
family with sequence similarity 214 member B |
chr15_+_63189554 | 1.28 |
ENST00000559006.1
ENST00000321437.9 |
RAB8B
|
RAB8B, member RAS oncogene family |
chr14_+_24398986 | 1.28 |
ENST00000382554.4
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr17_+_42020079 | 1.28 |
ENST00000393885.9
ENST00000393880.5 ENST00000393881.7 ENST00000462043.6 ENST00000449471.8 ENST00000316082.4 |
NKIRAS2
|
NFKB inhibitor interacting Ras like 2 |
chr6_+_46652968 | 1.27 |
ENST00000371347.10
|
SLC25A27
|
solute carrier family 25 member 27 |
chr13_-_33285682 | 1.25 |
ENST00000336934.10
|
STARD13
|
StAR related lipid transfer domain containing 13 |
chr14_-_34713788 | 1.25 |
ENST00000341223.8
|
CFL2
|
cofilin 2 |
chr15_+_74541200 | 1.23 |
ENST00000622429.1
ENST00000346246.10 |
ARID3B
|
AT-rich interaction domain 3B |
chr16_+_397183 | 1.20 |
ENST00000620944.4
ENST00000621774.4 ENST00000219479.7 |
NME4
|
NME/NM23 nucleoside diphosphate kinase 4 |
chr5_-_55712280 | 1.19 |
ENST00000506624.5
ENST00000513275.5 ENST00000513993.5 ENST00000396865.7 ENST00000503891.5 ENST00000507109.5 |
SLC38A9
|
solute carrier family 38 member 9 |
chr3_+_150408314 | 1.19 |
ENST00000361875.7
|
TSC22D2
|
TSC22 domain family member 2 |
chr11_+_119206298 | 1.17 |
ENST00000634586.1
ENST00000634840.1 ENST00000264033.6 ENST00000637974.1 |
CBL
|
Cbl proto-oncogene |
chr7_+_76461676 | 1.17 |
ENST00000425780.5
ENST00000456590.5 ENST00000451769.5 ENST00000324432.9 ENST00000457529.5 ENST00000446600.5 ENST00000430490.7 ENST00000413936.6 ENST00000423646.5 ENST00000438930.5 |
DTX2
|
deltex E3 ubiquitin ligase 2 |
chr9_+_125747345 | 1.15 |
ENST00000342287.9
ENST00000373489.10 ENST00000373487.8 |
PBX3
|
PBX homeobox 3 |
chr5_-_64768619 | 1.14 |
ENST00000513458.9
|
SREK1IP1
|
SREK1 interacting protein 1 |
chr1_+_154405193 | 1.13 |
ENST00000622330.4
ENST00000344086.8 |
IL6R
|
interleukin 6 receptor |
chr3_-_16264891 | 1.12 |
ENST00000488423.2
ENST00000383775.4 |
DPH3
|
diphthamide biosynthesis 3 |
chr3_+_172040554 | 1.12 |
ENST00000336824.8
ENST00000423424.5 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr2_+_17541157 | 1.11 |
ENST00000406397.1
|
VSNL1
|
visinin like 1 |
chr11_+_63813384 | 1.09 |
ENST00000294244.9
|
SPINDOC
|
spindlin interactor and repressor of chromatin binding |
chr3_+_122055355 | 1.07 |
ENST00000330540.7
ENST00000469710.5 ENST00000493101.5 |
CD86
|
CD86 molecule |
chrX_+_56232343 | 1.05 |
ENST00000468660.6
|
KLF8
|
Kruppel like factor 8 |
chr10_+_123666355 | 1.04 |
ENST00000284674.2
|
GPR26
|
G protein-coupled receptor 26 |
chr15_+_90001300 | 1.03 |
ENST00000268154.9
|
ZNF710
|
zinc finger protein 710 |
chr8_-_130443581 | 1.01 |
ENST00000357668.2
ENST00000518721.6 |
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
chr9_+_123356189 | 1.01 |
ENST00000373631.8
|
CRB2
|
crumbs cell polarity complex component 2 |
chr2_-_230068905 | 1.00 |
ENST00000457406.5
ENST00000295190.9 |
SLC16A14
|
solute carrier family 16 member 14 |
chr17_+_7439504 | 0.97 |
ENST00000575331.1
ENST00000293829.9 |
ENSG00000272884.1
FGF11
|
novel transcript fibroblast growth factor 11 |
chr20_-_49915509 | 0.96 |
ENST00000289431.10
|
SPATA2
|
spermatogenesis associated 2 |
chr19_+_33796846 | 0.96 |
ENST00000590771.5
ENST00000589786.5 ENST00000284006.10 ENST00000683859.1 ENST00000588881.5 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr1_-_23800402 | 0.95 |
ENST00000374497.7
ENST00000425913.5 |
GALE
|
UDP-galactose-4-epimerase |
chr6_+_11093753 | 0.94 |
ENST00000416247.4
|
SMIM13
|
small integral membrane protein 13 |
chr3_+_196867856 | 0.93 |
ENST00000445299.6
ENST00000323460.10 ENST00000419026.5 |
SENP5
|
SUMO specific peptidase 5 |
chr19_+_45079195 | 0.93 |
ENST00000591607.1
ENST00000591747.5 ENST00000270257.9 ENST00000391951.2 ENST00000587566.5 |
GEMIN7
MARK4
|
gem nuclear organelle associated protein 7 microtubule affinity regulating kinase 4 |
chr3_+_102435015 | 0.91 |
ENST00000306176.5
ENST00000466937.2 |
ZPLD1
|
zona pellucida like domain containing 1 |
chr2_+_74654228 | 0.91 |
ENST00000611975.4
ENST00000357877.7 ENST00000339773.9 ENST00000434486.5 |
SEMA4F
|
ssemaphorin 4F |
chrX_-_7148118 | 0.91 |
ENST00000486446.3
ENST00000381077.10 ENST00000412827.6 ENST00000424830.6 |
PUDP
|
pseudouridine 5'-phosphatase |
chr15_+_45587366 | 0.91 |
ENST00000220531.9
|
BLOC1S6
|
biogenesis of lysosomal organelles complex 1 subunit 6 |
chr9_-_74952904 | 0.91 |
ENST00000376854.6
|
C9orf40
|
chromosome 9 open reading frame 40 |
chr8_+_125430333 | 0.91 |
ENST00000311922.4
|
TRIB1
|
tribbles pseudokinase 1 |
chr8_-_123541197 | 0.90 |
ENST00000517956.5
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr11_-_12009082 | 0.90 |
ENST00000396505.7
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr9_+_75088498 | 0.90 |
ENST00000346234.7
|
OSTF1
|
osteoclast stimulating factor 1 |
chr20_-_34112205 | 0.89 |
ENST00000374980.3
|
EIF2S2
|
eukaryotic translation initiation factor 2 subunit beta |
chr1_+_100266195 | 0.86 |
ENST00000370128.9
ENST00000260563.4 |
RTCA
|
RNA 3'-terminal phosphate cyclase |
chr11_+_69641146 | 0.86 |
ENST00000227507.3
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr3_-_48188356 | 0.86 |
ENST00000351231.7
ENST00000437972.1 ENST00000302506.8 |
CDC25A
|
cell division cycle 25A |
chr1_-_119648165 | 0.86 |
ENST00000421812.3
|
ZNF697
|
zinc finger protein 697 |
chr22_-_35840218 | 0.86 |
ENST00000414461.6
ENST00000416721.6 ENST00000449924.6 ENST00000262829.11 ENST00000397305.3 |
RBFOX2
|
RNA binding fox-1 homolog 2 |
chr22_-_39244969 | 0.85 |
ENST00000331163.11
|
PDGFB
|
platelet derived growth factor subunit B |
chr15_+_81000913 | 0.85 |
ENST00000267984.4
|
TLNRD1
|
talin rod domain containing 1 |
chr9_-_70414657 | 0.84 |
ENST00000377126.4
|
KLF9
|
Kruppel like factor 9 |
chr19_+_13952466 | 0.83 |
ENST00000254337.10
|
DCAF15
|
DDB1 and CUL4 associated factor 15 |
chr5_-_172771187 | 0.83 |
ENST00000239223.4
|
DUSP1
|
dual specificity phosphatase 1 |
chr12_-_12562851 | 0.82 |
ENST00000298573.9
|
DUSP16
|
dual specificity phosphatase 16 |
chr1_+_204073104 | 0.81 |
ENST00000367204.6
|
SOX13
|
SRY-box transcription factor 13 |
chr1_+_167630093 | 0.81 |
ENST00000537350.5
ENST00000361496.3 ENST00000367854.8 |
RCSD1
|
RCSD domain containing 1 |
chr5_+_157743703 | 0.80 |
ENST00000286307.6
|
LSM11
|
LSM11, U7 small nuclear RNA associated |
chr15_+_88621290 | 0.80 |
ENST00000332810.4
ENST00000559528.1 |
AEN
|
apoptosis enhancing nuclease |
chr3_-_185825029 | 0.80 |
ENST00000382199.7
|
IGF2BP2
|
insulin like growth factor 2 mRNA binding protein 2 |
chr9_+_116153783 | 0.79 |
ENST00000328252.4
|
PAPPA
|
pappalysin 1 |
chr3_-_33096794 | 0.79 |
ENST00000416695.6
ENST00000399402.7 |
TMPPE
GLB1
|
transmembrane protein with metallophosphoesterase domain galactosidase beta 1 |
chr22_+_17563485 | 0.79 |
ENST00000327451.11
|
SLC25A18
|
solute carrier family 25 member 18 |
chr21_-_44711555 | 0.79 |
ENST00000323084.9
|
TSPEAR
|
thrombospondin type laminin G domain and EAR repeats |
chr1_+_12166978 | 0.78 |
ENST00000376259.7
ENST00000536782.2 |
TNFRSF1B
|
TNF receptor superfamily member 1B |
chr6_-_79947541 | 0.77 |
ENST00000369816.5
|
ELOVL4
|
ELOVL fatty acid elongase 4 |
chr15_-_51338575 | 0.77 |
ENST00000557858.5
ENST00000558328.5 ENST00000396402.6 ENST00000396404.8 ENST00000561075.5 ENST00000405011.6 ENST00000559980.5 ENST00000453807.6 |
CYP19A1
|
cytochrome P450 family 19 subfamily A member 1 |
chr22_+_50170720 | 0.76 |
ENST00000159647.9
ENST00000395842.3 |
PANX2
|
pannexin 2 |
chr12_+_88142290 | 0.76 |
ENST00000549011.5
ENST00000551088.1 ENST00000266712.11 |
TMTC3
|
transmembrane O-mannosyltransferase targeting cadherins 3 |
chr4_+_83536097 | 0.76 |
ENST00000395226.6
ENST00000264409.5 |
GPAT3
|
glycerol-3-phosphate acyltransferase 3 |
chr5_+_148826600 | 0.76 |
ENST00000305988.6
|
ADRB2
|
adrenoceptor beta 2 |
chr7_-_106661148 | 0.76 |
ENST00000523505.3
|
CCDC71L
|
coiled-coil domain containing 71 like |
chr3_-_122514876 | 0.75 |
ENST00000493510.1
ENST00000476916.5 ENST00000344337.11 ENST00000465882.5 |
KPNA1
|
karyopherin subunit alpha 1 |
chr7_+_107580215 | 0.74 |
ENST00000465919.5
ENST00000005259.9 ENST00000445771.6 ENST00000479917.5 ENST00000421217.5 ENST00000457837.5 |
BCAP29
|
B cell receptor associated protein 29 |
chr8_-_124372686 | 0.73 |
ENST00000297632.8
|
TMEM65
|
transmembrane protein 65 |
chr6_-_31139063 | 0.73 |
ENST00000259845.5
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr5_+_150778733 | 0.73 |
ENST00000526627.2
|
SMIM3
|
small integral membrane protein 3 |
chr2_+_233251571 | 0.73 |
ENST00000347464.9
ENST00000444735.5 ENST00000373525.9 ENST00000392017.9 ENST00000419681.5 |
ATG16L1
|
autophagy related 16 like 1 |
chr1_-_229342489 | 0.71 |
ENST00000366687.5
|
CCSAP
|
centriole, cilia and spindle associated protein |
chr19_+_38319807 | 0.70 |
ENST00000263372.5
|
KCNK6
|
potassium two pore domain channel subfamily K member 6 |
chr2_+_112482133 | 0.70 |
ENST00000233336.7
|
TTL
|
tubulin tyrosine ligase |
chr5_+_172834225 | 0.69 |
ENST00000393784.8
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment 1 |
chr6_-_99349647 | 0.69 |
ENST00000389677.6
|
FAXC
|
failed axon connections homolog, metaxin like GST domain containing |
chr8_+_24914942 | 0.68 |
ENST00000433454.3
|
NEFM
|
neurofilament medium |
chr2_-_36966503 | 0.68 |
ENST00000263918.9
|
STRN
|
striatin |
chr14_+_74881887 | 0.68 |
ENST00000334220.9
ENST00000626051.1 ENST00000554806.5 |
DLST
|
dihydrolipoamide S-succinyltransferase |
chr4_+_15002443 | 0.68 |
ENST00000538197.7
|
CPEB2
|
cytoplasmic polyadenylation element binding protein 2 |
chr10_+_18659382 | 0.68 |
ENST00000377275.4
|
ARL5B
|
ADP ribosylation factor like GTPase 5B |
chr16_-_88941198 | 0.67 |
ENST00000327483.9
ENST00000564416.1 |
CBFA2T3
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 |
chr8_+_69466617 | 0.67 |
ENST00000525061.5
ENST00000260128.8 ENST00000458141.6 |
SULF1
|
sulfatase 1 |
chr10_+_99659430 | 0.67 |
ENST00000370489.5
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
chr7_+_108569832 | 0.67 |
ENST00000249356.4
|
DNAJB9
|
DnaJ heat shock protein family (Hsp40) member B9 |
chr7_+_16646131 | 0.66 |
ENST00000415365.5
ENST00000433922.6 ENST00000630952.2 ENST00000258761.8 ENST00000405202.5 |
BZW2
|
basic leucine zipper and W2 domains 2 |
chrX_-_54357993 | 0.65 |
ENST00000375169.7
ENST00000354646.6 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr19_-_51020019 | 0.65 |
ENST00000309958.7
|
KLK10
|
kallikrein related peptidase 10 |
chr8_-_47738153 | 0.65 |
ENST00000408965.4
|
CEBPD
|
CCAAT enhancer binding protein delta |
chr15_+_82986198 | 0.64 |
ENST00000304191.4
|
RAMAC
|
RNA guanine-7 methyltransferase activating subunit |
chr3_-_69386079 | 0.63 |
ENST00000398540.8
|
FRMD4B
|
FERM domain containing 4B |
chrX_-_15335407 | 0.63 |
ENST00000635543.1
ENST00000542278.6 ENST00000482148.6 ENST00000333590.6 ENST00000637296.1 ENST00000634582.1 ENST00000634640.1 |
PIGA
|
phosphatidylinositol glycan anchor biosynthesis class A |
chr2_+_30231524 | 0.62 |
ENST00000395323.9
ENST00000406087.5 ENST00000404397.5 |
LBH
|
LBH regulator of WNT signaling pathway |
chr22_+_50185894 | 0.61 |
ENST00000380909.9
ENST00000303434.8 |
TRABD
|
TraB domain containing |
chr19_-_43596123 | 0.61 |
ENST00000422989.6
ENST00000598324.1 |
IRGQ
|
immunity related GTPase Q |
chr13_+_51584435 | 0.60 |
ENST00000612477.1
ENST00000298125.7 |
WDFY2
|
WD repeat and FYVE domain containing 2 |
chr12_-_95217373 | 0.60 |
ENST00000549499.1
ENST00000546711.5 ENST00000343958.9 |
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr16_-_2858154 | 0.60 |
ENST00000571228.1
ENST00000161006.8 |
PRSS22
|
serine protease 22 |
chr1_-_179229671 | 0.59 |
ENST00000502732.6
ENST00000392043.4 |
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase |
chr15_-_82806054 | 0.59 |
ENST00000541889.1
ENST00000334574.12 ENST00000561368.1 |
FSD2
|
fibronectin type III and SPRY domain containing 2 |
chr14_-_70809494 | 0.59 |
ENST00000381250.8
ENST00000554752.7 ENST00000555993.6 |
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9 |
chr19_+_1450113 | 0.59 |
ENST00000590469.6
ENST00000590877.5 ENST00000233607.6 |
APC2
|
APC regulator of WNT signaling pathway 2 |
chr9_+_100427123 | 0.58 |
ENST00000395067.7
|
MSANTD3
|
Myb/SANT DNA binding domain containing 3 |
chr12_-_42238203 | 0.58 |
ENST00000327791.8
ENST00000534854.7 |
YAF2
|
YY1 associated factor 2 |
chr22_-_45240859 | 0.57 |
ENST00000336156.10
|
KIAA0930
|
KIAA0930 |
chr6_+_4889992 | 0.57 |
ENST00000343762.5
|
CDYL
|
chromodomain Y like |
chr11_-_78341876 | 0.57 |
ENST00000340149.6
|
GAB2
|
GRB2 associated binding protein 2 |
chr21_+_29298890 | 0.56 |
ENST00000286800.8
|
BACH1
|
BTB domain and CNC homolog 1 |
chr15_+_22786610 | 0.56 |
ENST00000337435.9
|
NIPA1
|
NIPA magnesium transporter 1 |
chr1_-_84506565 | 0.56 |
ENST00000370641.3
ENST00000370645.9 |
GNG5
|
G protein subunit gamma 5 |
chr13_+_39038292 | 0.56 |
ENST00000470258.5
|
NHLRC3
|
NHL repeat containing 3 |
chr6_+_43427535 | 0.55 |
ENST00000372530.9
|
ABCC10
|
ATP binding cassette subfamily C member 10 |
chr14_+_52552830 | 0.55 |
ENST00000321662.11
|
GPR137C
|
G protein-coupled receptor 137C |
chr3_-_57693045 | 0.55 |
ENST00000311128.10
|
DENND6A
|
DENN domain containing 6A |
chr19_+_1753499 | 0.55 |
ENST00000382349.5
|
ONECUT3
|
one cut homeobox 3 |
chr1_-_208244375 | 0.55 |
ENST00000367033.4
|
PLXNA2
|
plexin A2 |
chr1_+_150149819 | 0.54 |
ENST00000369124.5
|
PLEKHO1
|
pleckstrin homology domain containing O1 |
chr11_+_117327829 | 0.54 |
ENST00000533153.5
ENST00000278935.8 ENST00000525416.5 |
CEP164
|
centrosomal protein 164 |
chr5_-_37371061 | 0.53 |
ENST00000513532.1
ENST00000231498.8 |
NUP155
|
nucleoporin 155 |
chr11_+_112074287 | 0.53 |
ENST00000532163.5
ENST00000280352.13 ENST00000393047.8 ENST00000526879.5 ENST00000525785.5 |
NKAPD1
|
NKAP domain containing 1 |
chr1_+_153259684 | 0.53 |
ENST00000368742.4
|
LORICRIN
|
loricrin cornified envelope precursor protein |
chr2_+_152718604 | 0.52 |
ENST00000326446.10
|
ARL6IP6
|
ADP ribosylation factor like GTPase 6 interacting protein 6 |
chrX_+_153642473 | 0.52 |
ENST00000370167.8
|
DUSP9
|
dual specificity phosphatase 9 |
chr7_+_38977904 | 0.52 |
ENST00000518318.7
ENST00000403058.6 |
POU6F2
|
POU class 6 homeobox 2 |
chr7_-_92833896 | 0.51 |
ENST00000265734.8
|
CDK6
|
cyclin dependent kinase 6 |
chr1_-_165356703 | 0.51 |
ENST00000342310.7
|
LMX1A
|
LIM homeobox transcription factor 1 alpha |
chr11_+_65333834 | 0.50 |
ENST00000528416.6
ENST00000415073.6 ENST00000252268.8 |
DPF2
|
double PHD fingers 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.6 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
1.0 | 5.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.9 | 2.7 | GO:0010752 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of cGMP-mediated signaling(GO:0010752) |
0.9 | 3.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.8 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.8 | 2.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 1.8 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
0.6 | 1.8 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) regulation of calcium-independent cell-cell adhesion(GO:0051040) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.5 | 2.7 | GO:1903238 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.5 | 1.6 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.5 | 1.5 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.5 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 1.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.4 | 3.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.8 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.4 | 1.1 | GO:0032681 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
0.3 | 2.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.0 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) negative regulation of membrane tubulation(GO:1903526) |
0.3 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 0.9 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.3 | 0.9 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 3.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 2.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 2.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.2 | 1.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 2.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 3.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.4 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.2 | 1.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 1.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 0.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.2 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.8 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.2 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 2.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 3.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.9 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.2 | 0.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.2 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 3.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 1.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.2 | 3.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 2.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.2 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.3 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.1 | 1.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 4.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.9 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 1.0 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 1.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 1.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.1 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) mitochondrial DNA repair(GO:0043504) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 2.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.4 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.3 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.1 | 0.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.1 | 0.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.2 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.1 | 0.9 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.7 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.5 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 1.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 2.8 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.1 | 0.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.3 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.4 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.3 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.5 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 2.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 3.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.0 | 0.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0071486 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
0.0 | 0.3 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.0 | 0.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.0 | 0.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.3 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 1.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.0 | 0.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.0 | 3.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 1.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 2.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 1.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 1.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 1.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
0.0 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.6 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 1.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.0 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.0 | 1.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.8 | 7.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.8 | 2.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 5.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 3.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.5 | 1.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 2.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.5 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 2.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 3.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 2.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 4.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 3.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 2.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 1.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 8.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.0 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 1.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 4.7 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 3.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.2 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 2.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 4.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.8 | 3.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.8 | 2.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.7 | 2.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 2.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.7 | 2.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.5 | 1.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 2.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
0.4 | 1.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 2.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 1.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.2 | 3.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 2.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 1.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 1.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.8 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 2.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 1.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.1 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 4.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 10.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 2.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.3 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 5.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.3 | GO:0046975 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 2.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.2 | GO:0043184 | C-X3-C chemokine binding(GO:0019960) vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.0 | 1.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 3.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 5.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 2.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 11.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 10.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 2.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 3.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 8.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 5.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 5.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 11.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 6.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 3.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 1.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 3.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 5.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |